SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 AMENDMENT NO 2
                                       TO
                                    FORM 10-K

              [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF

                       THE SECURITIES EXCHANGE ACT OF 1934

                   FOR THE FISCAL YEAR ENDED DECEMBER 31, 1999

                                       OR

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
                             SECURITIES ACT OF 1934

          FOR THE TRANSITION PERIOD FROM _______________ TO ___________

                         COMMISSION FILE NUMBER 0-25406
                                                -------

                     TECHNICAL CHEMICALS AND PRODUCTS, INC.
             (Exact name of registrant as specified in its charter)

   Florida                                                65-0308922
   -------                                                ----------
   (State or jurisdiction of                          (I.R.S. Employer
   incorporation or organization)                    Identification No.)

   3341 S.W. 15th Street, Pompano Beach, Florida             33069
   ---------------------------------------------             -----
   (Address of principal executive offices)                (Zip Code)

       Registrant's telephone number, including area code: (954) 979-0400

           Securities Registered Pursuant to Section 12(b) of the Act:

                                                     Name of exchange
  Title of each class                                on which registered
  -------------------                                -------------------
  None                                               None

Securities registered pursuant to 12(g) of the Act: Common Stock, $.001 par
value

         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding twelve months (or such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No ___

         Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]

         The aggregate market value of Common Stock held by non-affiliates as of
March 27, 2000 was approximately $39,411,432 (based upon the closing sale price
of $1.59375 per share on the Nasdaq National Market on March 27, 2000).

         As of March 27, 2000, 29,541,258 shares of the Registrant's $.001 par
value Common Stock were outstanding.

                       Documents Incorporated By Reference
                       -----------------------------------
         The Registrant's Definitive Proxy Statement related to the 2000
        Annual Shareholder's Meeting is incorporated by reference in Part
          III to the extent provided in Items 10, 11, 12 and 13 hereof.




<PAGE>
<TABLE>
<CAPTION>


                              Technical Chemicals and Products, Inc. and Subsidiaries
                                  Consolidated Statements of Stockholders' Equity

                                     (Amounts in thousands, except share data)

                                         Preferred Stock              Common Stock
                                   -------------------------------------------------------- Additional
                                     Number of                  Number of                    Paid-In      Accumulated
                                       Shares       Amount        Shares        Amount       Capital        Deficit        Total
                                   -------------------------------------------------------------------------------------------------
<S>                                               <C>            <C>             <C>          <C>          <C>            <C>
Balance at January 1, 1997                  -     $      -       9,938,634       $ 10         $ 39,608     $  (3,924)     $ 35,694
   Comprehensive loss:
      Net loss                              -            -               -          -                -        (4,489)       (4,489)
     Other comprehensive
       loss, net of tax -
       unrealized losses on
       investments, net                     -            -               -          -                -           (46)          (46)
                                                                                                                       -------------
   Comprehensive loss                       -            -               -          -                -             -        (4,535)
   Shares issued upon
     exercise of warrants                   -            -          76,402          -              199             -           199
                                   -------------------------------------------------------------------------------------------------
Balance at December 31, 1997                -            -      10,015,036         10           39,807        (8,459)       31,358
   Comprehensive loss:
      Net loss                              -            -               -          -                -        (9,827)       (9,827)
     Other comprehensive
       loss, net of tax -
       unrealized losses on
       investments, net                     -            -               -          -                -           (65)          (65)
                                                                                                                       -------------
   Comprehensive loss                       -            -               -          -                -             -        (9,892)
   Issuance of Series A
     preferred stock, net of
     issuance costs of $640            15,000       12,409               -          -            1,091             -        13,500
   Issuance of 150,000
     warrants with Series A
     preferred stock                        -            -               -          -              860             -           860
   Accrued dividends on
     Series A preferred stock               -          557               -          -             (557)            -             -
   Accretion to redemption
     value of Series A
     preferred stock                        -          473               -          -             (473)            -             -
   Purchase of common stock                 -            -         (87,961)         -             (339)            -          (339)
   Conversion of preferred
     stock to common stock               (300)        (308)         79,241          -              308             -             -
                                   -------------------------------------------------------------------------------------------------
Balance at December 31, 1998           14,700     $ 13,131      10,006,316       $ 10         $ 40,697     $ (18,351)     $ 35,487
                                   =================================================================================================


                                                                                                            (continued on next page)
<PAGE>

             Technical Chemicals and Products, Inc. and Subsidiaries
           Consolidated Statements of Stockholders' Equity (continued)
                    (Amounts in thousands, except share data)

                                          Preferred Stock              Common Stock
                                    -------------------------------------------------------- Additional
                                      Number of                  Number of                    Paid-In      Accumulated
                                        Shares       Amount        Shares        Amount       Capital        Deficit        Total
                                    ------------------------------------------------------------------------------------------------

Balance at December 31, 1998            14,700    $   13,131     10,006,316       $ 10        $ 40,697     $   (18,351)    $ 35,487

   Comprehensive loss:
      Net loss                               -             -              -          -               -         (15,339)     (15,339)
     Other comprehensive
       loss, net of tax -
       unrealized gains on
       investments, net                      -             -              -          -               -               8            8
                                                                                                                        ------------
   Comprehensive loss                        -             -              -          -               -               -      (15,331)
   Accrued dividends on
     Series A preferred stock                -           799              -          -            (799)              -            -
   Accretion to redemption
     value of Series A
     preferred stock                         -         2,118              -          -          (2,118)              -            -
   Conversion of preferred
     stock to common stock              (3,350)       (3,591)     4,528,228          5           3,586               -            -
   Shares issued to
     directors and employee                  -             -          7,000          -              10               -           10
   Issuance of 400,000
     warrants for services                   -             -              -          -             262               -          262
                                    ------------------------------------------------------------------------------------------------
Balance at December 31, 1999            11,350    $   12,457     14,541,544       $ 15        $ 41,638     $   (33,682)    $ 20,428
                                    ================================================================================================

</TABLE>

See accompanying notes.
<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                     TECHNICAL CHEMICALS AND PRODUCTS, INC.


                                     By:    /s/ Walter V. Usinowicz, Jr.
                                           -----------------------------
                                           Walter V. Usinowicz, Jr.
                                           Vice President, Chief Financial
                                           Officer (Principal Financial Officer
                                           and Principal Accounting Officer)

                                           Date: June 5, 2000